For citations:
Khatkov I.E., Andreyashkina I.I., Trotsenko I.D., Matveeva O.N., Reznikov V.A. The ICEDORA study: clinical and demographic characteristics and treatment regimens of patients with HR+ HER2- locally advanced or metastatic breast cancer receiving CDK4/6 inhibitors in real clinical practice. Real-World Data & Evidence. 2025;5(2):83-100. (In Russ.) https://doi.org/10.37489/2782-3784-myrwd-076. EDN: EFAKGL
Email this article 
Post a Comment 